The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial
Marc S Sabatine1, Elliott M Antman
1TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. msabatine@partners.org
Insights
The Thrombolysis In Myocardial Infarction (TIMI) risk score effectively stratifies unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEMI) patients. Higher TIMI scores correlate with increased risk of death, myocardial infarction, and urgent revascularization.
Area of Science:
- Cardiology
- Clinical Risk Assessment
- Acute Coronary Syndromes
Background:
- Unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) require accurate risk stratification for prognosis and treatment decisions.
- Existing methods may not fully integrate routine clinical variables for comprehensive risk assessment.
Purpose of the Study:
- To introduce and validate the Thrombolysis In Myocardial Infarction (TIMI) risk score for UA/NSTEMI.
- To identify key predictors of adverse cardiac events in UA/NSTEMI patients.
Main Methods:
- Utilized multivariable logistic regression to identify seven independent predictor variables.
- Constructed the TIMI risk score as a simple arithmetic sum of identified predictors.
- Validated the score in multiple UA/NSTEMI trials.
Main Results:
- Identified predictors include age, CAD risk factors, known CAD, anginal symptoms, aspirin use, ST-segment deviation, and cardiac markers.
- Demonstrated a significant increase in the rate of death, MI, or urgent revascularization with increasing TIMI risk scores (0-1: <5%; 6-7: >40%).
- The TIMI risk score effectively stratified patients and indicated a gradient of benefit for various treatments.
Conclusions:
- The TIMI risk score is a validated tool for risk stratification in UA/NSTEMI.
- It aids in optimizing clinical choices and guides treatment strategies, including invasive approaches and specific pharmacotherapies.
Abstract:
Risk stratification in unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI) can provide an estimate of a patient's prognosis and optimize clinical choices. The Thrombolysis In Myocardial Infarction (TIMI) risk score for UA/NSTEMI is an integrated approach that uses baseline variables that are part of the routine medical evaluation to identify patients at high risk for death and other major cardiac ischemic events. Using multivariable logistic regression, seven independent predictor variables were identified: age > or = 65 years, > or = 3 risk factors for coronary artery disease (CAD), known CAD (stenosis > or = 50%), severe anginal symptoms (> or = 2 anginal events in preceding 24 h), use of aspirin in the last seven days, ST-segment deviation > or = 0.05 mV, and elevated serum cardiac markers of necrosis. Each predictor carried similar prognostic weight; therefore, a risk score was constructed as the simple arithmetic sum of the number of predictors. The rate of death, MI, or urgent revascularization significantly increased as the TIMI risk score increased, ranging from < 5% for patients with a risk score of 0 or 1 to > 40% for patients with a risk score of 6 or 7. The risk score has been validated in several other trials of UA/NSTEMI. In addition, using the risk score to categorize patients also effectively defines a gradient for benefit with specific treatments such as low-molecular-weight heparins, glycoprotein IIb/IIIa inhibitors, and an early invasive strategy.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care